Published in Br J Pharmacol on May 01, 1989
Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation. Br J Pharmacol (1992) 0.78
Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo. Br J Pharmacol (1991) 0.78
Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex. Br J Pharmacol (1992) 0.77
Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice. J Neural Transm (Vienna) (2007) 0.76
Revisiting the role of raphe and serotonin in neuropsychiatric disorders. J Gen Physiol (2015) 0.76
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. J Psychiatry Neurosci (2017) 0.75
Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Transl Psychiatry (2017) 0.75
Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover. Br J Pharmacol (1994) 0.75
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol (1984) 1.74
Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol (1976) 1.66
An animal behavior model for studying central serotonergic synapses. Life Sci (1976) 1.47
"Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology (1977) 1.24
Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther (1978) 1.16
Cellular reactions to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathol (1987) 1.13
Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J Neurochem (1987) 1.13
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Life Sci (1987) 1.06
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J Neurochem (1988) 1.03
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Effects of electrical stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radioisotope method. J Neurochem (1972) 0.96
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats. Br J Pharmacol (1985) 0.92
Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome. Pharmacol Biochem Behav (1986) 0.91
Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology (1983) 0.90
p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett (1986) 0.89
Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex. Acta Physiol Scand (1977) 0.87
Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat. Eur J Pharmacol (1985) 0.87
Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses. Neuropharmacology (1982) 0.84
Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83
Effect of apomorphine on behaviour induced by 5-methoxy-N, N-dimethyl tryptamine: three different scoring methods give three different conclusions. Psychopharmacology (Berl) (1983) 0.81
Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Eur J Pharmacol (1985) 0.80
Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: effects of treatments altering precursor concentrations in brain. Neuropharmacology (1981) 0.78
Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice. J Pharm Pharmacol (1978) 0.77
Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163. Psychopharmacology (Berl) (1987) 0.77
Differential effects of reserpine and alpha-methyl-P-tyrosine on norepinephrine and dopamine induced behavioral activity. Psychopharmacologia (1973) 0.77
Differences in the duration of reserpine action in the rat depending on the measure employed. Int J Neuropharmacol (1968) 0.77
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol (1991) 1.63
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology (2005) 1.18
The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat. Neuropharmacology (1996) 1.17
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia. Mol Cell Neurosci (2006) 1.01
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proc Natl Acad Sci U S A (1990) 0.96
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Effects of ischaemia on neurotransmitter release from the isolated retina. J Neurochem (1994) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor. Neuropharmacology (2005) 0.95
Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport (1999) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
Inhibitors of caeruloplasmin. Biochem J (1967) 0.94
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med (1974) 0.93
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem (1976) 0.93
Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol (1987) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (1987) 0.93
Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions. J Neurochem (1974) 0.93
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol (1980) 0.92
The biochemistry of dyskinesias. Int Rev Neurobiol (1967) 0.92
Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Neuropharmacology (2000) 0.92
A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem (1978) 0.91
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology (2003) 0.91
Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice. Mol Psychiatry (2007) 0.91
3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. J Med Chem (2001) 0.90
Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology (1983) 0.90
Tryptophan metabolism in depression. J Neurol Neurosurg Psychiatry (1970) 0.90
Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol (1991) 0.90
Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification. Eur J Pharmacol (1994) 0.90
The biochemistry of the basal ganglia and Parkinson's disease. Postgrad Med J (1977) 0.90
3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid. J Neurochem (1985) 0.90
The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol (1993) 0.89
Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res (1988) 0.89
Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res (1979) 0.89
A comparison of an improved o-phthalaldehyde fluorometric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with L-tryptophan and p-chlorophenyl-alanine. Br J Pharmacol (1981) 0.89
Effects of lesions and drugs on brain tryptamine. J Neurochem (1974) 0.89
Unesterified fatty acids and the binding of tryptophan in human plasma. Clin Sci Mol Med (1974) 0.89
A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma. Anal Biochem (1977) 0.89
The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry (1970) 0.89
8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite (1986) 0.88
A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol (1990) 0.88
Transmitter precursors and metabolites in human ventricular cerebrospinal fluid. J Neurochem (1976) 0.88
Oral contraceptives, depression, and aminoacid metabolism. Lancet (1970) 0.88
Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Psychopharmacology (Berl) (1986) 0.88
Comparative studies of brain 5-hydroxytryptamine and tryptamine. Adv Biochem Psychopharmacol (1974) 0.87
Letter: Tryptophan plus a pyrrolase inhibitor for depression? Lancet (1975) 0.87
Relationships between headache and amine changes after administration of reserpine to migrainous patients. J Neurol Neurosurg Psychiatry (1969) 0.87
Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan. J Neurochem (1981) 0.86
Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology (Berl) (1990) 0.86